blank

Special 22-page Section
The Norman Prince Neurosciences Institute
John A. Robson, PhD; Karen Furie, MD;
Steven Rasmussen, MD
Guest Editors

15

The Norman Prince Neurosciences Institute: Linking Research to Clinical Care
John A. Robson, PhD; Karen Furie, MD; Steven Rasmussen, MD

18

Neurotechnology: A New Approach for Treating Brain Disorders
John A. Robson, PhD; R. John Davenport, PhD

22

The Brown University Traumatic Brain Injury Research Consortiumand the Norman Prince Neurosciences Institute
Jeffrey Rogg, MD; Heather Spader, MD; BethANY J. Wilcox, BS; Anna Ellermeier, MD; Steve Correia, PhD; Adam Chodobski, PhD; Joanna Szmydynger-Chodobska, PhD; Neha Raukar, MD; Jason T. Machan, PhD; W. Curt LaFrance, Jr., MD, MPH; Joseph J. Crisco, PhD

27

Advances in Stroke Over the Past Decade
Brian Silver, MD

31

The Rhode Island Consortium for Autism Research and Treatment (RI-CART): A New Statewide Autism Collaborative
Alan Gerber, MA; Eric Morrow, MD, PhD; Stephen J. Sheinkopf, PhD; Thomas Anders, MD

CONTRIBUTIONS

35

HPV Knowledge and Vaccine Acceptance in an Uninsured Hispanic Population in Providence, RI
Jeff Chau, Farzana Kibria, Macayla Landi, Melissa Reilly, Tania Medeiros, MPH; Heather Johnson, MLIS; Shahla Yekta, PhD, MPH; Anne S. De Groot, MD

CASE REPORT

40

Solitary Pulmonary Nodule: Pleuropulmonary Synovial Sarcoma
Robert C. Ward, MD; Ariel E. Birnbaum, MD; Bassam I. Aswad, MD; Terrance T. Healey, MD

PUBLIC HEALTH

44

What is MOLST?
Edward Martin, MD, MPH; James V. McDonald, MD, MPH

47

Health by Numbers: Increasing Trend of HPV-Associated Oropharyngeal Cancers
among Males in Rhode Island, 1987–2011
Junhie Oh, BDS, MPH; John Fulton, PhD; Tricia Washburn, BS

50

Vital Statistics
Colleen A. Fontana, State Registrar